Menninger Research Scientist Launches Clinical Study of Adults With Opioid Use Disorder

The Menninger Clinic and Baylor College of Medicine have opened a clinical trial, led by principal investigator Hyuntaek Oh, PhD, pictured, to study brain function changes before and after non-invasive brain stimulation (transcranial magnetic stimulation, or TMS) for adults with opioid use disorder.

The study participant cannot be taking medication treatment for opioid use, including methadone, buprenorphine or Naltrexone, at the time of recruitment; however, the study participant who has a history of medication treatment might be eligible to participate. 

Participants will receive $20 for each transcranial magnetic stimulation (rTMS) session at The Menninger Clinic — up to 5 sessions — and $25 for each of the two brain neuroimaging sessions at Baylor College of Medicine. 

The clinical research study is funded by a grant from the National Institutes on Drug Abuse. The purpose of the study is to examine the efficacy of rTMS in treating opioid use disorder.

For more information, contact Dr. Oh.